Cyfendus Anthrax Vaccine Wins FDA Approval
XTalks
JULY 25, 2023
Cyfendus functions by stimulating the production of antibodies targeted against the protective antigen protein. These antibodies play a crucial role in providing protection by effectively neutralizing the cytotoxic lethal toxin and edema toxin of B. The recommended administration involves two doses, each of 0.5 Overall, 66.3
Let's personalize your content